Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Myricx Bio Announces Expansion of its Leadership Team to Advance NMTi-ADCs into Clinical Development
Steen Lisby, M.D., D.MSc. joins as Chief Medical OfficerJesper Valbjørn, M.Sc. joins as Senior Vice President CMCOngoing team expansion at Myricx Bio's new facilities in London’s Canary Wharf biotech...
-
AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States
LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of...
-
TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Testicular Cancer Awareness Month is here, and Movember – the world’s leading men’s health charity – is asking men to get hands-on with their health...
-
Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global Natural Killer (NK) Cell Therapy Clinical Trials, Proprietary Technologies, Collaborations and Market Opportunity Insight 2025 Report Highlights...
-
Castle will present data on DecisionDx-Melanoma at the 11th World Congress of Melanoma and 21st European Association of Dermato-Oncology (EADO) Congress.
-
REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with...
-
BOSTON, Mass, April 01, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc. (“Radiance” or the “Company”), a clinical stage biopharmaceutical company advancing Antibody Drug Conjugates (‘ADCs’), today...
-
BALTIMORE, April 01, 2025 (GLOBE NEWSWIRE) -- Two’s company, but a lump is a crowd! April is Testicular Cancer Awareness Month, and the Urology Care Foundation (UCF), the official foundation of the...
-
Newly Appointed Board Chair, Philip Astley-Sparke, Brings Transatlantic Late-Stage Development, Regulatory and Commercial Expertise Strengthened Leadership and Expanded U.S. Presence Positions SynOx...